Home > Insider Trading > Filing (0001567619-19-002399)

Filing Details

Accession Number:: 0001567619-19-002399
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-05 17:34:36
Reporting Period:: 2019-02-01

Accepted Time:: 2019-02-05 17:34:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561387	Health Insurance Innovations Inc.	HIIQ	Insurance Agents, Brokers & Service (6411)	461282634

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1569128	D Michael Hershberger	C/O Health Insurance Innovations, Inc. 15438 North Florida Ave., Suite 201 Tampa FL 33613	Cfo, Secretary And Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2019-02-01	3,850	$40.02	85,329	No	4	S	Direct
Class A Common Stock	Disposition	2019-02-04	40,389	$40.31	44,940	No	4	S	Direct
Class A Common Stock	Disposition	2019-02-05	4,687	$40.03	40,253	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Appreciation Rights	$10.45	2021-05-21	10,000	10,000	Direct
Common Stock	Stock Appreciation Rights	$4.95	2022-07-01	15,000	15,000	Direct
Common Stock	Stock Appreciation Rights	$4.99	2022-09-16	22,500	22,500	Direct
Common Stock	Stock Appreciation Rights	$5.20	2023-09-16	40,972	40,972	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-05-21	10,000	10,000	Direct
2022-07-01	15,000	15,000	Direct
2022-09-16	22,500	22,500	Direct
2023-09-16	40,972	40,972	Direct

Footnotes

Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.22, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $41.58, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.08, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
These stock-settled stock appreciation rights were granted under the long Term Incentive Plan of Health Insurance Innovations, Inc. (the "Plan") and vest 20% on the first three anniversaries of grant date and 40% on the fourth anniversary, subject to the terms of the Plan and an award agreement under the Plan.
These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first and second anniversaries of grant date and 50% on the third anniversary, subject to the terms of the Plan and an award agreement under the Plan.